Osteoarthritis in europe: Impact on health status, work productivity and use of pharmacotherapies in five European countries

Rheumatology (United Kingdom)

Volumn 53, Issue 5, 2014, Pages 937-947

  Kingsbury, Sarah R ^a   Gross, Hillary J ^b   Isherwood, Gina ^b   Conaghan, Philip G ^a  

^a St James s University Hospital   (United Kingdom)

^b KANTAR HEALTH   (United States)

Author keywords

Health utility; Medication; Osteoarthritis; Work productivity

Indexed keywords

HEALTH UTILITY; MEDICATION; OSTEOARTHRITIS; WORK PRODUCTIVITY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DRUG THERAPY; FEMALE; FRANCE; GERMANY; GREAT BRITAIN; HEALTH STATUS; HEALTH SURVEYS; HUMANS; ITALY; MALE; MIDDLE AGED; OSTEOARTHRITIS; SELF REPORT; SPAIN; TREATMENT OUTCOME; WORK CAPACITY EVALUATION;

EID: 84898781973     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket463     Document Type: Article

References (44)

1. World Health Organization. The burden of musculoskeletal conditions at the start of the new millennium. Geneva: World Health Organization, 2003.
2. Murphy L, Schwartz TA, Helmick CG et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum 2008;59: 1207-13.
3. Murphy LB, Helmick CG, Schwartz TA et al. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage 2010;18:1372-9.
4. Murray CJ, Vos T, Lozano R et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2197-223.
5. Vos T, Flaxman AD, Naghavi M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2163-96.
6. Woolf AD. The bone and joint decade. Strategies to reduce the burden of disease: the Bone and Joint Monitor Project. J Rheumatol Suppl 2003;67:6-9.
7. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004;111:77-83.
8. Soares JJ, Jablonska B. Psychosocial experiences among primary care patients with and without musculoskeletal pain. Eur J Pain 2004;8:79-89.
9. Keenan A, McKenna S, Doward L et al. Development and validation of a needs-based quality of life instrument for osteoarthritis. Arthritis Care Res 2008;59:841-8.
10. Stewart WF, Ricci JA, Chee E et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-54.
11. Yelin E, Sonneborn D, Trupin L. The prevalence and impact of accommodations on the employment of persons 51-61 years of age with musculoskeletal conditions. Arthritis Care Res 2000;13:168-76.
12. Zhang W, Doherty M, Arden N et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64:669-81.
13. Zhang W, Doherty M, Leeb BF et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66:377-88.
14. Fernandes L, Hagen KB, Bijlsma JW et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 2013;72:1125-35.
15. Zhang W, Nuki G, Moskowitz RW et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.
16. Conaghan PG, Dickson J, Grant RL. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 2008;336:502-3.
17. Blamey R, Jolly K, Greenfield S et al. Patterns of analgesic use, pain and self-efficacy: a cross-sectional study of patients attending a hospital rheumatology clinic. BMC Musculoskelet Disord 2009;10:137.
18. Sale JE, Gignac M, Hawker G. How 'bad' does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis. Arthritis Rheum 2006;55:272-8.
19. Kantar Health. National Health and Wellness Survey, 2011 [EU Big 5]. Princeton, NJ, USA: 2012.
20. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 2001;79:373-4.
21. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
22. Ware JJ, Kosinski M, Turner-Bowker D. User's manual for the SF-12v2TM health survey with a supplement documenting SF-12- health survey. Lincoln, NE, USA: QualityMetric, 2001.
23. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
24. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4: 353-65.
25. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
26. Keenan AM, Tennant A, Fear J et al. Impact of multiple joint problems on daily living tasks in people in the community over age fifty-five. Arthritis Rheum 2006;55: 757-64.
27. Carnes D, Parsons S, Ashby D et al. Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study. Rheumatology 2007;46: 1168-70.
28. Sale JE, Gignac M, Hawker G. The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis. J Rheumatol 2008;35:335-42.
29. Manheim LM, Dunlop D, Song J et al. Relationship between physical activity and health-related utility among knee osteoarthritis patients. Arthritis Care Res 2012;64: 1094-8.
30. Salaffi F, Carotti M, Grassi W. Health-related quality of life in patients with hip or knee osteoarthritis: comparison of generic and disease-specific instruments. Clin Rheumatol 2005;24:29-37.
31. Salaffi F, Carotti M, Stancati A et al. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res 2005;17:255-63.
32. Salaffi F, De Angelis R, Stancati A et al. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Exp Rheumatol 2005;23: 829-39.
33. Kotlarz H, Gunnarsson CL, Fang H et al. Osteoarthritis and absenteeism costs: evidence from US National Survey Data. J Occup Environ Med 2010;52:263-8.
34. Maetzel A, Li LC, Pencharz J et al. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004; 63:395-401.
35. White AG, Birnbaum HG, Janagap C et al. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med 2008;50:998-1005.
36. Dibonaventura M, Gupta S, McDonald M et al. Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey. BMC Musculoskelet Disord 2011;12:83.
37. Fryback DG, Dunham NC, Palta M et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care 2007;45: 1162-70.
38. van der Waal JM, Terwee CB, van der Windt DA et al. The impact of non-traumatic hip and knee disorders on healthrelated quality of life as measured with the SF-36 or SF-12. A systematic review. Qual Life Res 2005;14:1141-55.
39. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41:582-92.
40. Bandieri E, Chiarolanza A, Luppi M et al. Prescription of opioids in Italy: everything, but the morphine. Ann Oncol 2009;20:961-2.
41. Galvez R. Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences. J Pain Palliat Care Pharmacother 2009;23: 346-56.
42. Kingsbury SR, Hensor EMA, Walsh CEA et al. How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative. Arthritis Res Ther 2013;15: R106.
43. Rosenwald K, Ertl K, Fletcher KE et al. Patterns of arthritis medication use in a community sample. J Prim Care Community Health 2012;3:272-7.
44. Dunbar-Jacob J, Erlen JA, Schlenk EA et al. Adherence in chronic disease. Annu Rev Nurs Res 2000;18:48-90.